SOX2, a core transcription factor in pluripotency and stemness, is frequently overexpressed in cancers, including osteosarcoma, where it sustains tumor initiation, metastasis, and therapy resistance (Huang P. et al., 2024). Here, SOX2 is linked to osteosarcoma.